Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 338

1.

Apolipoprotein E induces antiinflammatory phenotype in macrophages.

Baitsch D, Bock HH, Engel T, Telgmann R, Müller-Tidow C, Varga G, Bot M, Herz J, Robenek H, von Eckardstein A, Nofer JR.

Arterioscler Thromb Vasc Biol. 2011 May;31(5):1160-8. doi: 10.1161/ATVBAHA.111.222745. Epub 2011 Feb 24.

2.

MicroRNA-155 deficiency results in decreased macrophage inflammation and attenuated atherogenesis in apolipoprotein E-deficient mice.

Du F, Yu F, Wang Y, Hui Y, Carnevale K, Fu M, Lu H, Fan D.

Arterioscler Thromb Vasc Biol. 2014 Apr;34(4):759-67. doi: 10.1161/ATVBAHA.113.302701. Epub 2014 Feb 6.

3.

Lack of mitogen-activated protein kinase phosphatase-1 protects ApoE-null mice against atherosclerosis.

Shen J, Chandrasekharan UM, Ashraf MZ, Long E, Morton RE, Liu Y, Smith JD, DiCorleto PE.

Circ Res. 2010 Mar 19;106(5):902-10. doi: 10.1161/CIRCRESAHA.109.198069. Epub 2010 Jan 21.

4.

Macrophage beta3 integrin suppresses hyperlipidemia-induced inflammation by modulating TNFalpha expression.

Schneider JG, Zhu Y, Coleman T, Semenkovich CF.

Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2699-706. Epub 2007 Oct 19. Erratum in: Arterioscler Thromb Vasc Biol. 2008 Feb;28(2):e12.

5.

Low density receptor-related protein 1 (LRP1) promotes anti-inflammatory phenotype in murine macrophages.

May P, Bock HH, Nofer JR.

Cell Tissue Res. 2013 Dec;354(3):887-9. doi: 10.1007/s00441-013-1699-2. Epub 2013 Aug 21.

PMID:
23963646
7.

Interleukin-1 receptor type-1 in non-hematopoietic cells is the target for the pro-atherogenic effects of interleukin-1 in apoE-deficient mice.

Shemesh S, Kamari Y, Shaish A, Olteanu S, Kandel-Kfir M, Almog T, Grosskopf I, Apte RN, Harats D.

Atherosclerosis. 2012 Jun;222(2):329-36. doi: 10.1016/j.atherosclerosis.2011.12.010. Epub 2011 Dec 17.

PMID:
22236482
8.

Mediator 1 Is Atherosclerosis Protective by Regulating Macrophage Polarization.

Bai L, Li Z, Li Q, Guan H, Zhao S, Liu R, Wang R, Zhang J, Jia Y, Fan J, Wang N, Reddy JK, Shyy JY, Liu E.

Arterioscler Thromb Vasc Biol. 2017 Aug;37(8):1470-1481. doi: 10.1161/ATVBAHA.117.309672. Epub 2017 Jun 22.

PMID:
28642237
9.

Apolipoprotein E enhances microRNA-146a in monocytes and macrophages to suppress nuclear factor-κB-driven inflammation and atherosclerosis.

Li K, Ching D, Luk FS, Raffai RL.

Circ Res. 2015 Jun 19;117(1):e1-e11. doi: 10.1161/CIRCRESAHA.117.305844. Epub 2015 Apr 22.

10.

Essential role for the (hepatic) LDL receptor in macrophage apolipoprotein E-induced reduction in serum cholesterol levels and atherosclerosis.

Van Eck M, Van Dijk KW, Herijgers N, Hofker MH, Groot PH, Van Berkel TJ.

Atherosclerosis. 2001 Jan;154(1):103-12.

PMID:
11137088
11.

Anti-inflammatory immune skewing is atheroprotective: Apoe−/−FcγRIIb−/− mice develop fibrous carotid plaques.

Harmon EY, Fronhofer V 3rd, Keller RS, Feustel PJ, Zhu X, Xu H, Avram D, Jones DM, Nagarajan S, Lennartz MR.

J Am Heart Assoc. 2014 Dec;3(6):e001232. doi: 10.1161/JAHA.114.001232.

12.

Bone marrow transplantation in apolipoprotein E-deficient mice. Effect of ApoE gene dosage on serum lipid concentrations, (beta)VLDL catabolism, and atherosclerosis.

Van Eck M, Herijgers N, Yates J, Pearce NJ, Hoogerbrugge PM, Groot PH, Van Berkel TJ.

Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):3117-26.

13.

Apolipoprotein E-/- Mice Lacking Hemopexin Develop Increased Atherosclerosis via Mechanisms That Include Oxidative Stress and Altered Macrophage Function.

Mehta NU, Grijalva V, Hama S, Wagner A, Navab M, Fogelman AM, Reddy ST.

Arterioscler Thromb Vasc Biol. 2016 Jun;36(6):1152-63. doi: 10.1161/ATVBAHA.115.306991. Epub 2016 Apr 14.

14.

SOCS3 deficiency promotes M1 macrophage polarization and inflammation.

Qin H, Holdbrooks AT, Liu Y, Reynolds SL, Yanagisawa LL, Benveniste EN.

J Immunol. 2012 Oct 1;189(7):3439-48. Epub 2012 Aug 27. Erratum in: J Immunol. 2016 Jul 1;197(1):387-9.

15.

Apolipoprotein E suppresses the type I inflammatory response in vivo.

Ali K, Middleton M, Puré E, Rader DJ.

Circ Res. 2005 Oct 28;97(9):922-7. Epub 2005 Sep 22.

16.

Angiotensin-(1-7) modulates renal vascular resistance through inhibition of p38 mitogen-activated protein kinase in apolipoprotein E-deficient mice.

Potthoff SA, Fähling M, Clasen T, Mende S, Ishak B, Suvorava T, Stamer S, Thieme M, Sivritas SH, Kojda G, Patzak A, Rump LC, Stegbauer J.

Hypertension. 2014 Feb;63(2):265-72. doi: 10.1161/HYPERTENSIONAHA.113.02289. Epub 2013 Nov 4.

17.

Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression.

Horio E, Kadomatsu T, Miyata K, Arai Y, Hosokawa K, Doi Y, Ninomiya T, Horiguchi H, Endo M, Tabata M, Tazume H, Tian Z, Takahashi O, Terada K, Takeya M, Hao H, Hirose N, Minami T, Suda T, Kiyohara Y, Ogawa H, Kaikita K, Oike Y.

Arterioscler Thromb Vasc Biol. 2014 Apr;34(4):790-800. doi: 10.1161/ATVBAHA.113.303116. Epub 2014 Feb 13.

18.

Postprandial lipoproteins and the molecular regulation of vascular homeostasis.

Botham KM, Wheeler-Jones CP.

Prog Lipid Res. 2013 Oct;52(4):446-64. doi: 10.1016/j.plipres.2013.06.001. Epub 2013 Jun 15. Review.

PMID:
23774609
19.

AMPK activation inhibits expression of proinflammatory mediators through downregulation of PI3K/p38 MAPK and NF-κB signaling in murine macrophages.

Huang BP, Lin CH, Chen HM, Lin JT, Cheng YF, Kao SH.

DNA Cell Biol. 2015 Feb;34(2):133-41. doi: 10.1089/dna.2014.2630. Epub 2014 Dec 23.

PMID:
25536376
20.

Induction of oxidative stress by oxidized LDL via meprinα-activated epidermal growth factor receptor in macrophages.

Gao P, Wang XM, Qian DH, Qin ZX, Jin J, Xu Q, Yuan QY, Li XJ, Si LY.

Cardiovasc Res. 2013 Mar 1;97(3):533-43. doi: 10.1093/cvr/cvs369. Epub 2012 Dec 17.

PMID:
23250920

Supplemental Content

Support Center